中安科股份有限公司 关于前期重整涉及相关事项的 进展公告

Core Points - The company has completed the execution of its restructuring plan as confirmed by the Wuhan Intermediate People's Court [1] - The company has compensated investors for losses amounting to 865.80 million yuan due to false statements [2] - The company has adjusted its debt claim list following the withdrawal of lawsuits with China Merchants Securities [2] Summary by Sections - Restructuring Plan: The restructuring plan of the company has been confirmed as executed by the court, marking a significant milestone in its recovery process [1] - Investor Compensation: The total compensation for investors due to false statements stands at 86.58 million yuan, indicating the financial impact of previous misstatements [2] - Legal Developments: The company and China Merchants Securities have mutually withdrawn their lawsuits, leading to adjustments in the debt claim list and a potential increase in non-operating profit for 2025 by approximately 19.71 million yuan [2]